The three receptor tyrosine kinases c-KIT, VEGFR2 and PDGFRα, closely spaced at 4q12, show increased protein expression in triple-negative breast cancer.
<h4>Background</h4>Triple-negative breast cancer (TNBC) is a heterogeneous subgroup of breast cancer with poor prognosis and no targeted therapy available. Receptor tyrosine kinases (RTKs) are emerging targets in anticancer therapy and many RTK-inhibiting drugs are currently being develo...
Guardado en:
Autores principales: | Sara Jansson, Pär-Ola Bendahl, Dorthe Aamand Grabau, Anna-Karin Falck, Mårten Fernö, Kristina Aaltonen, Lisa Rydén |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5e62c022483b4633ba2ff2e91cdc4372 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
High CYP27A1 expression is a biomarker of favorable prognosis in premenopausal patients with estrogen receptor positive primary breast cancer
por: Maria Inasu, et al.
Publicado: (2021) -
Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT.
por: Patrice Dubreuil, et al.
Publicado: (2009) -
Tyrosine kinase inhibitors induce down-regulation of c-Kit by targeting the ATP pocket.
por: Diane D'allard, et al.
Publicado: (2013) -
Tyrosine Kinase Inhibitors in Adult Glioblastoma: An (Un)Closed Chapter?
por: Paula Aldaz, et al.
Publicado: (2021) -
Nanopore sequencing for the screening of myeloid and lymphoid neoplasms with eosinophilia and rearrangement of PDGFRα, PDGFRβ, FGFR1 or PCM1-JAK2
por: Simone Romagnoli, et al.
Publicado: (2021)